Pharmaceuticals

Precision Oncology Market Analysis With Focus On Growth Potential And Future Outlook

May 4, 2026May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Precision Oncology Market Expected To Change From 2026 To 2030?

The precision oncology market has experienced significant expansion in recent years. It is projected to expand from $106.21 billion in 2025 to $117.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. Factors contributing to its historical growth include the scarcity of genomic sequencing technologies, the dependence on traditional chemotherapy, a global rise in cancer cases, the early embrace of immunotherapy, and increasing research activities in molecular oncology.

The precision oncology market is poised for significant expansion in the coming years, projected to reach $175.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This anticipated growth is driven by factors such as the advancement of next-generation sequencing platforms, the growing integration of bioinformatics and artificial intelligence within oncology, the increasing embrace of liquid biopsy and molecular imaging techniques, the broadening availability of personalized treatment choices, and enhanced research partnerships between medical institutions and pharmaceutical firms. Key trends anticipated during this period encompass the wider application of targeted cancer therapies informed by molecular profiling, the continued rise in the use of liquid biopsy and other non-invasive diagnostic approaches, the expansion of biomarker-based testing for tailored treatment strategies, the increasing merger of immunotherapy with genomic sequencing, and a heightened concentration on rare and challenging-to-treat cancer varieties.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Significant Factors Are Influencing The Precision Oncology Market Expansion?

A growing understanding and move towards tailored medical treatments are anticipated to fuel the expansion of the precision oncology market in the future. These therapies involve treatments uniquely designed for an individual’s genetic profile, biological markers, and distinct disease traits, with the goal of improving efficacy and minimizing adverse reactions. The rise of personalized therapies is attributed to progress in genomic technologies, which facilitate the accurate detection of mutations that drive diseases, thereby enabling more potent and focused interventions. Precision oncology plays a crucial role in advancing personalized therapies through the application of genomic and molecular profiling, which customizes cancer treatment according to the unique genetic composition of a patient’s tumor. As an illustration, in February 2023, as reported by GOV.UK, a UK-based government department, the Health and Social Care Secretary entered into a Memorandum of Understanding with BioNTech SE. This agreement seeks to further cancer vaccine research in England, with an objective to provide 10,000 personalized therapy doses to UK patients by 2030. Consequently, the heightened awareness and transition towards personalized therapies are fueling the expansion of the precision oncology market.

Which Segment Types Are Examined In The Precision Oncology Market Segment Study?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Market Trends Are Affecting The Precision Oncology Market?

Leading companies operating in the precision oncology market are concentrating on developing innovative strategies, such as the molecular tumor board, to support personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board typically refers to a dedicated panel of specialists tasked with analyzing and interpreting complex genomic and molecular test data, thereby informing precision-driven cancer therapies that are specifically tailored to the unique tumor characteristics of individual patients. An example of this occurred in December 2024, when Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic. This was part of three personalized cancer care initiatives aimed at transforming treatment through data-driven, genomic-focused strategies. This clinic provides customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise and effective treatments while reducing side effects. Such an approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by carefully aligning therapies with the distinct molecular features of a patient’s cancer.

Which Players Are Part Of The Competitive Landscape Of The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Get The Full Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Region Represents The Largest Share Of The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Precision Oncology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795